Medi-Cal FFS Naloxone Utilization SFY 2018-19 Drug Naloxone Injection Naloxone Nasal Total
# of Claims
Amount Reimbursed ($)
597
$30,963
47,312
$6,075,504
47,909
$6,106,468
Figure Courtesy of California Department of Health Care Services. Time frame is fiscal year 18/19 from July 1, 2018 through June 30, 2019 crease-availability-all-forms-naloxone-help-reduce-opioid-overdose?utm_campaign=092019_Statement_FDA’s%20efforts%20 to%20increase%20availability%20of%20all%20forms%20of%20 naloxone&utm_medium=email&utm_source=Eloqua Concerns exist that moving naloxone OTC will reduce insurance coverage for the medication and create a financial hardship in some cases. (Davis et al 2020). Currently THN is a covered pharmacy benefit for all Medi-Cal beneficiaries. This could continue to be the case if naloxone became an OTC drug. However, a prescription would have to generated for the OTC product in order to have the drug paid for by the state. Covered California is a health insurance exchange enables eligible individuals to purchase health insurance coverage at federally subsidized rates. Over the counter medications may or may not be covered by Covered California Health Insurance exchange or other health insurance plans. Medicare drug plans aren’t required to cover over-the-counter drugs. https://www.medicare.gov/Pubs/pdf/11109-Your-Guide-toMedicare-Prescrip-Drug-Cov.pdf Plan coverage may vary with naloxone formulation and may be limited to generic naloxone. Currently there is no generic naloxone nasal spray formulation marketed in the United States. An argument could be made for health care coverage plan to cover the purchase of naloxone OTC in order to reduce health care costs involving opioid overdose. Otherwise legislation changing regulations could be considered. It is uncertain how much time needed to change regulations and how health in-
surance plans will react. There is no guarantee that insurance will cover costs of naloxone OTC to avoid taking away from a vulnerable population the access to THN that the current system provides. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/ PrescriptionDrugCovContra/Downloads/QACY2007OTCsandUM_051206.pdf Some naloxone formulation could retain legend status and remain covered by insurance. It is unclear what would be the determination of which THN formulation would be available OTC. States and localities could subsidize the cost of naloxone with grant programs. However insurance benefits that cover naloxone are less volatile than grant dependent Overdose Education and Naloxone Distribution (OEND) programs. A recent modeling study found naloxone conversion to overthe-counter status is could lead to increased pharmacy sales. (Murphy et al., 2019). This could lead to a decrease in naloxone pricing but not with certainty. Physicians and other health care providers may still need to furnish a THN prescription for patients seeking a naloxone OTC formulation which is a requirement for third party reimbursement. The degree to which a conversion of naloxone to OTC would affect public health will depend on how the change affects those persons most likely to encounter an overdose. Changing THN to OTC could reduce insurance coverage for naloxone resulting in greater out of pocket cost for people relying on Covered California Health Insurance exchange/Medicare programs. Low-income individuals who are more challenged by price increases may not have insurance that covers a THN OTC formulation. This could result in reduced naloxone access to those in need. References:
• C. S. Davis, D. Carr. Over the counter naloxone needed to save lives in the United States. Preventive Medicine, Volume 130,2020, 105932, SSN 0091-7435. https://www.ncbi. nlm.nih.gov/pubmed/31770540 • S.M. Murphy, J.R. Morgan, P.J. Jeng, B.R. Schackman Will converting naloxone to over-the-counter status increase pharmacy sales? Health Serv. Res., 54 (4) (2019), pp. 764772 https://onlinelibrary.wiley.com/doi/pdf/10.1111/14756773.13125
Medical Times From the Past, From Page 43 vances were surging. Coronary bypass, arterial stents and heart transplants all brought new life to thousands of patients. New drugs to lower cholesterol,maintain regular rhythm, maintain normal blood pressure, and dissolve clots, all contributed to the breakthroughs in maintaining health in cardio vascular and cerebral vascular disorders. Breakthroughs in radiation techniques and new chemotherapeutic drugs are extending the five year survival in cancer patients. Medical progress has not always been consistent. It has fal46 | The Bulletin
tered along the way, and during the Middle Ages must have seemed hopeless. Scientific breakthroughs came in clusters. They came from all over the world, but in the nineteenth and twentieth centuries, they were largely from Europe and the United States. Is the end in sight? The answer is sadly no. Alzheimers and cancer are just two examples of mountains still to climb, but they will be climbed. Medical research is relentless and will continue to uncover the secrets to a healthy life. That long and winding road is getting shorter!
